"I think the drug companies are going to do some big, expensive trials, but until they're done with real objectivity, I worry, " says Raymond Woosley , vice president of health sciences at the University of Arizona and a noted drug-safety expert.

FORBES: The Heavy Weight Of Clinical Trials